383 related articles for article (PubMed ID: 29968311)
1. Proposal of a new scoring formula for the Dermatology Life Quality Index in psoriasis.
Rencz F; Gulácsi L; Péntek M; Poór AK; Sárdy M; Holló P; Szegedi A; Remenyik É; Brodszky V
Br J Dermatol; 2018 Nov; 179(5):1102-1108. PubMed ID: 29968311
[TBL] [Abstract][Full Text] [Related]
2. DLQI-R scoring improves the discriminatory power of the Dermatology Life Quality Index in patients with psoriasis, pemphigus and morphea.
Rencz F; Gulácsi L; Péntek M; Szegedi A; Remenyik É; Bata-Csörgő Z; Bali G; Hidvégi B; Tamási B; Poór AK; Hajdu K; Holló P; Kinyó Á; Sárdy M; Brodszky V
Br J Dermatol; 2020 May; 182(5):1167-1175. PubMed ID: 31419310
[TBL] [Abstract][Full Text] [Related]
3. A detailed analysis of 'not relevant' responses on the DLQI in psoriasis: potential biases in treatment decisions.
Rencz F; Poór AK; Péntek M; Holló P; Kárpáti S; Gulácsi L; Szegedi A; Remenyik É; Hidvégi B; Herszényi K; Jókai H; Beretzky Z; Brodszky V
J Eur Acad Dermatol Venereol; 2018 May; 32(5):783-790. PubMed ID: 29114942
[TBL] [Abstract][Full Text] [Related]
4. Utility of the Dermatology Life Quality Index at initiation or switching of biologics in real-life Japanese patients with plaque psoriasis: Results from the ProLOGUE study.
Imafuku S; Kanai Y; Murotani K; Nomura T; Ito K; Ohata C; Yamazaki F; Miyagi T; Takahashi H; Okubo Y; Saeki H; Honma M; Tada Y; Mabuchi T; Higashiyama M; Kobayashi S; Hashimoto Y; Seishima M; Kakuma T
J Dermatol Sci; 2021 Mar; 101(3):185-193. PubMed ID: 33495058
[TBL] [Abstract][Full Text] [Related]
5. A Rasch model analysis of two interpretations of 'not relevant' responses on the Dermatology Life Quality Index (DLQI).
Rencz F; Mitev AZ; Szabó Á; Beretzky Z; Poór AK; Holló P; Wikonkál N; Sárdy M; Kárpáti S; Szegedi A; Remenyik É; Brodszky V
Qual Life Res; 2021 Aug; 30(8):2375-2386. PubMed ID: 33683650
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of the Frequency of "Not Relevant" Responses on the Dermatology Life Quality Index by Sociodemographic Characteristics of Patients With Psoriasis.
Barbieri JS; Shin DB; Syed MN; Takeshita J; Gelfand JM
JAMA Dermatol; 2020 Apr; 156(4):446-450. PubMed ID: 32101261
[TBL] [Abstract][Full Text] [Related]
7. Sustained Psoriasis Area and Severity Index, Dermatology Life Quality Index and EuroQol-5D response of biological treatment in psoriasis: 10 years of real-world data in the Swedish National Psoriasis Register.
Hjalte F; Carlsson KS; Schmitt-Egenolf M
Br J Dermatol; 2018 Jan; 178(1):245-252. PubMed ID: 28644904
[TBL] [Abstract][Full Text] [Related]
8. Generating EQ-5D-3L Utility Scores from the Dermatology Life Quality Index: A Mapping Study in Patients with Psoriasis.
Davison NJ; Thompson AJ; Turner AJ; Longworth L; McElhone K; Griffiths CEM; Payne K;
Value Health; 2018 Aug; 21(8):1010-1018. PubMed ID: 30098665
[TBL] [Abstract][Full Text] [Related]
9. Exploring the relationship between EQ-5D, DLQI and PASI, and mapping EQ-5D utilities: a cross-sectional study in psoriasis from Hungary.
Herédi E; Rencz F; Balogh O; Gulácsi L; Herszényi K; Holló P; Jókai H; Kárpáti S; Péntek M; Remenyik É; Szegedi A; Brodszky V
Eur J Health Econ; 2014 May; 15 Suppl 1():S111-9. PubMed ID: 24832842
[TBL] [Abstract][Full Text] [Related]
10. Durable dermatology life quality index improvements in patients on biologics associated with psoriasis areas and severity index: a longitudinal study.
Chaptini C; Quinn S; Marshman G
Australas J Dermatol; 2016 Aug; 57(3):e72-5. PubMed ID: 26010650
[TBL] [Abstract][Full Text] [Related]
11. [Assessment of health-related quality of life in psoriasis patients in Hungary].
Poór AK; Sárdy M; Cserni T; Brodszky V; Holló P; Gulácsi L; Remenyik É; Szegedi A; Rencz F; Péntek M
Orv Hetil; 2018 May; 159(21):837-846. PubMed ID: 29779387
[TBL] [Abstract][Full Text] [Related]
12. Decision-Analytic Modeling for Time-Effectiveness of the Sequence of Induction Treatments for Moderate to Severe Plaque Psoriasis.
Zidane M; Dressler C; Gaskins M; Nast A
JAMA Dermatol; 2019 Dec; 155(12):1380-1389. PubMed ID: 31617856
[TBL] [Abstract][Full Text] [Related]
13. Measurement properties of the EQ-5D-5L compared to the EQ-5D-3L in psoriasis patients.
Poór AK; Rencz F; Brodszky V; Gulácsi L; Beretzky Z; Hidvégi B; Holló P; Kárpáti S; Péntek M
Qual Life Res; 2017 Dec; 26(12):3409-3419. PubMed ID: 28875430
[TBL] [Abstract][Full Text] [Related]
14. Does the Dermatology Life Quality Index (DLQI) underestimate the disease-specific burden of psoriasis patients?
Langenbruch A; Radtke MA; Gutknecht M; Augustin M
J Eur Acad Dermatol Venereol; 2019 Jan; 33(1):123-127. PubMed ID: 30160802
[TBL] [Abstract][Full Text] [Related]
15. Validation and application of the Dermatology Life Quality Index score, a modification of the DLQI score, in psoriasis patients.
Zou Q; Luo Y; Hao D; Li M; Jihui C
J Health Popul Nutr; 2024 Jun; 43(1):92. PubMed ID: 38909238
[TBL] [Abstract][Full Text] [Related]
16. EQ-5D health utilities: exploring ways to improve upon responsiveness in psoriasis.
Pickard AS; Gooderham M; Hartz S; Nicolay C
J Med Econ; 2017 Jan; 20(1):19-27. PubMed ID: 27471948
[TBL] [Abstract][Full Text] [Related]
17. Is the DLQI appropriate for medical decision-making in psoriasis patients?
Poór AK; Brodszky V; Péntek M; Gulácsi L; Ruzsa G; Hidvégi B; Holló P; Kárpáti S; Sárdy M; Rencz F
Arch Dermatol Res; 2018 Jan; 310(1):47-55. PubMed ID: 29128966
[TBL] [Abstract][Full Text] [Related]
18. Psoriasis Area Severity Index (PASI) and the Dermatology Life Quality Index (DLQI): the correlation between disease severity and psychological burden in patients treated with biological therapies.
Mattei PL; Corey KC; Kimball AB
J Eur Acad Dermatol Venereol; 2014 Mar; 28(3):333-7. PubMed ID: 23425140
[TBL] [Abstract][Full Text] [Related]
19. Definition of psoriasis severity in routine clinical care: current guidelines fail to capture the complexity of long-term psoriasis management.
Augustin M; Langenbruch A; Gutknecht M; Reich K; Körber A; Maaßen D; Mrowietz U; Thaçi D; von Kiedrowski R; Radtke MA
Br J Dermatol; 2018 Dec; 179(6):1385-1391. PubMed ID: 30334253
[TBL] [Abstract][Full Text] [Related]
20. Life quality among psoriasis patients based on Dermatology Life Quality Index evaluation and its association with psoriasis severity in China: a cross-sectional study.
Chen Y; Wei L; Song Y; Zhang R; Kuai L; Li B; Wang R
Ann Med; 2023 Dec; 55(1):2231847. PubMed ID: 37417705
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]